RPS20P5

Across TCGA pan-cancer cohorts, RPS20P5 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RPS20P5’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where RPS20P5 RNA is repressed in tumor relative to normal tissue. In most cancer types RPS20P5 is over-expressed in tumor, although a few such as STAD show the opposite, repressed pattern.

STAD, LUAD, and KIRC are the cancer types where RPS20P5 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPS20P5 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	Male	IV	−0.524	.002	3	view →
LUAD	Female	All	+0.102	.025	1	view →
KIRC	All	All	+0.035	.038	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

RPS20P5–STAD

Open the STAD breakdown →